Osteoarthritis in 2016: Anti-NGF treatments for pain — two steps forward, one step back?

Nature Reviews Rheumatology 13, 76 (2017). doi:10.1038/nrrheum.2016.224 Authors: Nancy E. Lane & Maripat Corr Inhibitors of β-nerve growth factor (NGF) have impressive effects in reducing musculoskeletal pain, but have also been associated with adverse events of unclear aetiology. Several studies in the past year have sought to clarify the relative benefits and risks of anti-NGF treatment.
Source: Nature Reviews Rheumatology - Category: Rheumatology Authors: Tags: Year in Review Source Type: research